What Are Biomarkers? A Comprehensive Guide

Every time a doctor orders a blood test or a radiologist reads an MRI scan, they are working with biomarkers. In environmental science and medicine alike, biomarkers serve as measurable windows into what is happening inside a living organism at any given moment. Whether the trigger is a chemical pollutant, a pathogen, or a chronic disease, biomarkers capture the biological response – often before any outward symptoms appear. Understanding what biomarkers are, how they differ from related concepts like bioindicators, and where they are applied in real-world practice is foundational to grasping how modern environmental health science operates.

Understanding biomarkers 🔗

According to the National Institute of Environmental Health Sciences (NIEHS), a biomarker – short for biological marker – is an objective measure that captures what is happening in a cell or an organism at a given moment. More formally, as established in environmental toxicology literature, a biomarker is “a change in biological response, ranging from molecular through cellular and physiological responses to behavioral changes, which can be related to exposure to or toxic effects of environmental chemicals.” In simpler terms, a biomarker is any measurable substance, structure, or process in a living organism that signals a normal biological process, a disease state, or a response to an environmental exposure or treatment.

Biomarkers can come from a wide range of biological samples: blood, urine, saliva, hair, bone, tissue biopsies, or even medical images of living tissue. Baylor University’s environmental science program defines the term broadly to include any tools and technologies that measure substances or processes influencing or predicting the incidence of an outcome or disease. What unifies all biomarkers is that they are objective and measurable – they provide concrete data, not just subjective symptom reports.

One of the most important features of biomarkers is their role as early warning systems. A person may feel perfectly healthy while their blood already shows elevated cholesterol – a well-known biomarker for cardiovascular disease risk. Similarly, high blood lead levels can signal the need to investigate neurological and cognitive impacts, particularly in children, long before visible symptoms emerge. This predictive capability is what makes biomarkers indispensable in both medicine and environmental health monitoring.

Categories of biomarkers 🔗

Biomarkers are not a single uniform tool. Environmental health researchers broadly classify them into three main types: biomarkers of exposure, biomarkers of effect, and biomarkers of susceptibility.

Biomarkers of exposure 🔗

These measure whether an organism has been exposed to a substance, and to what degree. For instance, mercury concentration in hair is a reliable biomarker of exposure to methylmercury in human populations. In occupational health settings, these markers are routinely used to ensure workers are not being exposed to harmful levels of industrial chemicals. In environmental epidemiology, they help establish links between chemical exposures and downstream health effects.

Biomarkers of effect 🔗

These reflect a measurable biological change that has occurred as a result of exposure. They capture the organism’s response – not just whether contact happened, but what happened inside the body as a result. DNA strand breaks caused by certain pesticides, or enzyme inhibition in fish exposed to organophosphate compounds, fall into this category. In environmental biotechnology, commonly used effect biomarkers include cytochrome P450 enzyme induction, acetylcholinesterase inhibition, and metallothionein proteins, each of which signals specific types of chemical contamination in aquatic and terrestrial organisms.

Biomarkers of susceptibility 🔗

Susceptibility biomarkers assess an individual’s vulnerability to the toxic effects of an exposure. These can include genetic variants that alter how efficiently someone metabolizes a toxin, or metabolic and nutritional factors that either amplify or buffer the body’s response. For example, elevated baseline cholesterol is associated with heightened vulnerability to a range of toxic exposures. Susceptibility biomarkers are particularly useful for understanding why two people exposed to the same environmental chemical can have dramatically different health outcomes.

Biomarkers vs. bioindicators 🔗

Biomarkers are often confused with bioindicators, but these two concepts operate at fundamentally different scales and serve different scientific purposes. Understanding the distinction matters especially in environmental science, where both tools are used in pollution monitoring and ecological risk assessment.

Biomarkers measure biological responses at the molecular, cellular, or physiological level within an individual organism. They are sensitive, typically short-term responses that function as early warning signals of stress or exposure. When scientists measure stress proteins in fish living in polluted water, or detect DNA damage in earthworms from contaminated soil, they are using biomarkers. The response occurs within the individual and provides direct mechanistic evidence of what is happening inside that organism’s biology.

Bioindicators, by contrast, operate at higher levels of biological organization – the individual organism, population, community, or ecosystem. They track patterns such as changes in species abundance, shifts in community composition, or changes in reproductive rates across populations. A classic example is the use of lichen species to monitor air quality: the presence or absence of particular lichen species across an area tells researchers about long-term ecosystem health, not just what is happening in a single organism at a single moment.

The core distinction, as described in ecological risk assessment literature, is that biomarkers concentrate on measurement attributes, while bioindicators require validation and must be demonstrably linked to effects at the organism, population, or community level. This means bioindicators carry stronger ecological relevance for long-term environmental management, while biomarkers excel at providing early, sensitive, mechanistic signals of biological change.

In practice, the two approaches complement each other. Biomarkers provide the detailed cellular and molecular evidence of how a pollutant is affecting an organism. Bioindicators then reveal whether those individual-level impacts are scaling up to affect entire populations or ecosystems. A biomarker might detect cellular oxidative stress in individual mussels; a bioindicator would later show whether mussel populations across a coastal system are declining as a result.

Real-world applications of biomarkers 🔗

Biomarkers are not purely theoretical tools – they are embedded in routine clinical practice, environmental monitoring programs, and public health research worldwide. The following examples demonstrate their range of application.

C-reactive protein (CRP) for inflammation 🔗

CRP is one of the most widely used biomarkers in clinical medicine. CRP is an acutely sensitive marker of systemic inflammation, infection, and tissue damage, produced by the liver in response to pro-inflammatory signals. When levels rise in the blood, it indicates the body is mounting an inflammatory response. Clinically, elevated CRP is used to monitor conditions including rheumatoid arthritis, Crohn’s disease, cardiovascular disease, and post-surgical infections. Elevated CRP is considered a high-value biomarker for identifying increased risk of heart failure and cardiovascular mortality. In environmental health contexts, CRP has been measured in populations exposed to air pollution, heavy metals, and other environmental stressors to assess systemic inflammatory burden.

MRI as an imaging biomarker 🔗

Not all biomarkers come from blood tests. Medical imaging itself functions as a biomarker category. Magnetic resonance imaging (MRI) generates detailed cross-sectional images of internal organs, tissues, and structures, making it invaluable for detecting abnormalities that blood tests cannot capture on their own. MRI can reveal structural changes such as synovial inflammation in joints, brain lesions, liver fat accumulation, or tumor progression – all of which constitute measurable biological indicators. Muscle volume, intramuscular fat content, and brain volume changes detected by MRI are all recognized imaging biomarkers used to assess disease progression or treatment response. Importantly, research has shown that MRI can detect subclinical inflammation – for example, active joint synovitis – even when blood-based biomarkers like CRP and ESR show normal values, highlighting how different biomarker types work better in combination than in isolation.

Lead levels in blood and teeth 🔗

NIEHS-supported research has found that baby teeth from children with autism spectrum disorder contain higher lead concentrations and lower levels of zinc and manganese than teeth from children without the condition, suggesting that early-life metal exposures may be captured as exposure biomarkers in biological tissues. Blood lead levels remain a standard biomarker for diagnosing lead poisoning and for triggering clinical intervention in children, particularly in communities near industrial sites or with older housing stock.

Metallothioneins in aquatic organisms 🔗

In environmental monitoring, metallothionein proteins in fish, mussels, and other aquatic organisms serve as biomarkers of heavy metal pollution. Metallothioneins are induced by exposure to metals such as zinc, copper, cadmium, and mercury, and their elevated levels in gill or kidney tissue signal contamination even when the water column itself tests within acceptable chemical limits. This is why biomarkers are considered more ecologically informative than chemical assays alone – they reveal what the organism’s biology has actually absorbed and responded to.

Gut microbiome and stool biomarkers 🔗

An emerging area of environmental biomarker research focuses on the gut. Stool samples can be analyzed for pesticides, metals such as arsenic and lead, persistent organic pollutants, and even microplastics as biomarkers of dietary and environmental exposure. Beyond measuring specific contaminants, the diversity and composition of gut microbiota in fecal samples is increasingly recognized as a biomarker of cumulative toxic exposure, since the microbial community profile reflects the range of substances passing through the digestive system over time.

Why biomarkers matter in environmental science 🔗

The value of biomarkers in environmental science extends beyond individual health monitoring. As established in environmental health research, biomarkers connect molecular and cellular changes along the pathway from exposure to clinical disease, helping scientists identify which exposures are biologically active, at what doses, and in which populations. They allow researchers to move beyond simply measuring pollution in air or water and instead document what that pollution is doing inside living organisms.

This is particularly significant for risk assessment. Biomarkers of susceptibility help identify which individuals or communities face disproportionate health risks from the same environmental exposure. Biomarkers of exposure provide legally and scientifically defensible evidence in environmental litigation and public health policy. And biomarkers of effect establish the mechanistic links necessary to move from correlation to causation in epidemiological research.

The development and validation of reliable biomarkers is a long-term scientific process – moving from laboratory experiments, through pilot human studies, to large-scale epidemiological investigations. But once validated, they become powerful, standardized tools that translate the invisible language of molecular biology into actionable public health information.

What do you think? Given that biomarkers can detect biological changes from environmental exposures before symptoms appear, how should this capability shape the way industries are regulated or monitored near residential communities? And with biomarkers now extending to imaging, genetics, and the gut microbiome, what challenges do you see in setting universal standards for what counts as a meaningful biomarker signal versus normal biological variation?

References

1. https://www.niehs.nih.gov/health/topics/science/biomarkers
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC4284972/
3. https://environmentalscience.artsandsciences.baylor.edu/research/biomedical-sciences/biomarkers
4. https://www.openaccessgovernment.org/ebook/biomarkers-in-environmental-health-research/178781/
5. https://www.researchgate.net/publication/301270117_Modern_Approaches_into_Biochemical_and_Molecular_Biomarkers_Key_Roles_in_Environmental_Biotechnology
6. https://www.sciencedirect.com/topics/neuroscience/bioindicators
7. https://www.researchgate.net/publication/232840302_Bioindicators_Versus_Biomarkers_in_Ecological_Risk_Assessment
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC7152028/
9. https://www.optimaldx.com/research-blog/biomarkers-of-inflammation-crp
10. https://scientificamerican.blog/inflammation-diagnostics-biomarkers-healthcare-providers/
11. https://pubs.acs.org/doi/abs/10.1021/es960920a